Top
image credit

New molecule shows great promise for future treatment of many cancers

July 17, 2018

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers.

The new molecule successfully targets a protein that plays a major role in the growth of most cancers. This protein target is called proliferating cell nuclear antigen (PCNA), otherwise known as the human sliding clamp.

“PCNA is required for DNA replication and is therefore essential for rapidly dividing cancer cells,” says project leader Dr John Bruning, Senior Research Fellow at the University’s Institute for Photonics and Advanced Sensing (IPAS).

Read More on The Medical News